Skip to main content
. 2016 Aug 8;27(1):1–15. doi: 10.1080/09602011.2016.1190533

Table 1. The Single-Case Reporting Guideline in BEhavioural Interventions (SCRIBE) 2016 checklist.

Item number Topic Item description
TITLE and ABSTRACT
1 Title Identify the research as a single-case experimental design in the title
2 Abstract Summarize the research question, populalion, design, methods including in!ervention/s (independent variable/s) and target behavior/s and any other outcome/s (dependent variable/s), results, and conclusions
INTRODUCTION
3 Scientific background Describe the scientific background to identify issue/s under analysis, current scientific knowledge, and gaps in that knowledge base
4 Aims State the purpose/aims of the study, research question/s, and, if applicable, hypotheses
METHOD
  DESIGN  
5 Design ldemify the design (e.g., withdrawal/reversal, multiple-baseline, alternating-treatments, changing-criterion, some combination thereof, or adaptive design) and describe the phases and phase sequence (whether determined a priori or data-driven) and, if applicable, criteria for phase change
6 Procedural changes Describe any procedural changes that occurred during the course of the investigation after the start of the study
7 Replication Describe any planned replication
8 Randomization State whether randomization was used, and if so, describe the randomization method and the elements of the study that were randomized
9 Blinding State whether blinding/masking was used, and if so, describe who was blinded/masked
  PARTICIPANT/S or UNIT/S  
10 Selection criteria State the inclusion and exclusion criteria, if applicable, and the method of recruitment
11 Participant characteristics For each participant, describe the demographic characteristics and clinical (or other) features relevant to the research question, such that anonymity is ensured
  CONTEXT  
12 Setting Describe characteristics of the setting and location where the study was conducted
  APPROVALS  
13 Ethics State whether ethics approval was obtained and indicate if and how informed consent and/or assent were obtained
  MEASURES and MATERIALS  
14 Measures Operationally define all target behaviors and outcome measures, describe reliability and validity, state how they were selected, and how and when they were measured
15 Equipment Clearly describe any equipment and/or materials (e.g., technological aids, biofeedback, computer programs, intervention manuals or other material resources) used to measure target behavior/s and other outcome/s or deliver the interventions
  INTERVENTIONS  
16 Intervention Describe the intervention and control condition in each phase, including how and when they were actually administered, with as much detail as possible to facilitate attempts at replication
17 Procedural fidelity Describe how procedural fidelity was evaluated in each phase
  ANALYSIS  
18 Analyses Describe and justify all methods used to analyze data
RESULTS
19 Sequence completed For each participant, report the sequence actually completed, including the number of trials for each session for each case. For participant/s who did not complete, state when they stopped and the reasons
20 Outcomes and estimation For each participant, report results, including raw data, for each target behavior and other outcome/s
21 Adverseevents State whether or not any adverse events occurred for any participant and the phase in which they occurred
DISCUSSION
22 Interpretation Summarize findings and interpret the results in the context of current evidence
23 Limitations Discuss limitations, addressing sources of potential bias and imprecision
24 Applicability Discuss applicability and implications of the study findings
DOCUMENTATION
25 Protocol If available, state where a study protocol can be accessed
26 Funding Identify source/s of funding and other support; describe the role of funders